Cannabis Law Report

AUGUST 3, 2021

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Research and Development 105

Research and Development Data Conditions Therapy 105

WeedAdvisor

JULY 21, 2019

The Financial Times explains: “The excitement over cannabis in Colombia has reached fever pitch with some local media reports suggesting the country could supply two-fifths of the world’s marijuana and earn more from it than it does from coal or cut flowers. Strict Regulations. . Regulations will be difficult to meet and maintain.

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

CannaMD

APRIL 11, 2024

A recent study published in the Journal of the American Heart Association suggests a link between marijuana use and increased cardiovascular risks, sparking widespread media coverage with alarming headlines. This highlights the need for more rigorous, long-term studies to accurately assess the true impact of cannabis on heart health.

Media 52

Media Marijuana Data Conditions 52

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

MARCH 23, 2022

A Pennsylvania bill meant to promote research into the therapeutic potential of psilocybin mushrooms for certain mental health conditions may be in jeopardy, with the sponsor saying that the chair of a key House committee is expressing reservations even after the legislation was amended in an effort to build support. The legislation from Rep.

Legislation 98

Legislation Media Data Policy 98

Cannabis Law Report

MARCH 3, 2022

Former President Bill Clinton has apparently been hearing a lot about the therapeutic potential of CBD products for pain management lately, and, according to a now-deleted media report, said at a recent conference appearance that broad interest in the topic should spur regulators to develop standards for the cannabinoid. Ganjapreneur report.

Media 52

Media CBD Events THC 52

United Patients Group

JUNE 8, 2023

It replaces traditional paper-based forms and manual data entry, improving efficiency, accuracy, and patient experience. Data Capture: This tool can capture patient information like demographic details, contact information, insurance details, medical history, allergies, and medication information.

Patients 52

Patients Data Collective Environment 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JUNE 30, 2021

Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Cannabis Law Report

JULY 6, 2021

In connection with the Closing, Harrison Baum , Chief Executive Officer of Daily High Club, has joined the High Tide team as Director of Digital Marketing to oversee all social media initiatives for High Tide globally. 1 As of June 21st, 2021, based on analytics data provided by Alexa Internet, Inc. ABOUT DHC SUPPLY LLC.

Consumption 116

Consumption Retail Media Events 116

Cannabis Law Report

MAY 6, 2022

At this time the FDA has not evaluated what, if anything, these products are effective for and what appropriate doses might be, or whether there are counterindications for persons taking other drugs or having any other health conditions. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”.

THC 52

THC CBD Media Food 52

Cannabis Law Report

JULY 29, 2021

Ben Kaplan, CEO of Ehave, said, “We strongly believe there is a genetic predisposition to this condition and will be conducting a large-scale genetic analysis to isolate an individuals’ risk profile. If these visual disturbances occur frequently, you may have a condition called hallucinogen persisting perception disorder (HPPD).

Research and Development 105

Research and Development Conditions Data Patients 105

Veriheal

AUGUST 12, 2021

All patients were carefully chosen from social media posts and Realm of Caring patient registries, with follow-up survey responses being collected from a subgroup of 190 participants. For example, rather than having researchers carry out a controlled investigation, each study subject provided self-reported data.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

JULY 29, 2021

Notably, both the low and high ends of observed transaction data – $900 and $1,650 per kilogram – were up compared to May.”. Last year, farmers fought grasshopper infestations and it looks like this year conditions are ripe for an even bigger outbreak. The Hemp Benchmarks June report noted that the U.S.

Hemp 131

Hemp CBD Data THC 131

MMJ Recs

MAY 3, 2024

The Arkansas medical marijuana program, established through the Arkansas Medical Marijuana Amendment in 2016, has paved the way for patients suffering from a variety of debilitating conditions to find relief and improved quality of life. Typically, medical marijuana cards need to be renewed annually.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Cannabis Law Report

JULY 30, 2021

The Company’s seven primary business segments include Retail, Agriculture, QSR & Hospitality, Media Technology & Gaming, Clean Energy and New Age Wellness. For media inquiries: Davis Richardson. The Company’s investment partnerships range from minority positions to large strategic holdings with active advisory mandates.

Events 105

Events Business Media Conditions 105

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. Forward-Looking Statement Disclaimer.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

Research and Development 112

Research and Development Data THC Clinical Trials 112

Veriheal

AUGUST 17, 2021

In an official statement to media sources, Dr. Drake said ; “We don’t find any evidence to support the theory that cannabis functions as a gateway drug… if anything, we find that recreational cannabis legalization decreases opioid-related emergency department visits.”

Data 98

Data Cannabis Media Collective 98

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.”

CBD 98

CBD Safety Topical Food 98

Cannabis Law Report

JULY 9, 2021

European cannabis media outlet Newsweed reports. The head of the Criminal Court number 8 of Valencia considers that “the condition of cannabis consumer has been accredited” with the analysis of the hair samples analyzed by the National Institute of Toxicology and Forensic Sciences.

CBD 105

CBD Seed-To-Sale Sativa Extraction 105

Cannabis Law Report

NOVEMBER 16, 2021

Forward-looking information is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management’s perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances.

Data 52

Data Events Research and Development Business 52

SpeedWeed

JULY 30, 2021

The CBD Insider’s 2021 US CBD Consumer Report provides some data around the CBD industry and what consumers want from CBD brands that can help savvy businesses stand out in the marketplace. Based on the data from the study, the breakdown of why U.S. A specific health condition or some other reason : 8.8%. Pets : 5.9%.

CBD 52

CBD Pets Data Research and Development 52

Cannabis Law Report

JUNE 13, 2021

THC exposure for 60 minutes had only marginal effect on nociception under the conditions assessed. LJARI donated funds for some of the lobster purchases but was not directly involved in the design of the experiments, analysis and interpretation of data or the decision to submit the study for publication. Pain News Network reports.

THC 100

THC Research and Development History Media 100

Veriheal

DECEMBER 27, 2022

Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. Researchers recruited 641 participants from Western Europe and America via Facebook groups, university mailing lists, and social media forums. The subjective nature of self-reported data can plague research.

Research and Development 101

Research and Development Therapy Consumption DEA 101

Cannabis Law Report

NOVEMBER 9, 2021

Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. With the addition of KWC, we can now reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

JUNE 1, 2021

The acquisition is expected to close in Q3 2021, subject to closing conditions and covenants customary for this type of transaction, including, without limitation, obtaining MED and local licensing approval. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. About Schwazze.

Seed-To-Sale 85

Seed-To-Sale Cultivation Events Strains 85

Cannabis Law Report

JULY 20, 2021

Along with this transaction, our last two acquisitions have increased High Tide’s social media reach by leaps and bounds, giving us access to an invaluable potential customer base,” said Raj Grover, President and Chief Executive Officer of High Tide. Pursuant to the terms of the Transaction, High Tide USA Inc.,

Retail 111

Retail Consumption Media Events 111

Cannabis Law Report

JANUARY 6, 2022

He serves as the primary spokesperson and point of contact with the analyst and investment community and is also responsible for the timely dissemination of information and data to these important stakeholders. Anderson will be responsible for Anebulo’s global investor relations and public relations programs. Anebulo Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

Cannabis Law Report

AUGUST 10, 2021

A Phase 2 trial of MYMD-1 as a therapy for COVID-19-associated depression and cytokine elevation is expected to begin by the fourth quarter of 2021 with initial trial data expected in the first quarter of 2022. Media Contact: Will Johnson. About Oravax Medical. Oravax was established in March 2021 by Oramed Pharmaceuticals Inc.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. Media: media@mymd.com. is the master regulator of inflammation, MYMD-1’s function as a TNF-? inhibitor targets the root cause of aging, not just the symptoms,” said Adam Kaplin, M.D.,

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

JUNE 7, 2021

FTSE Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. Media Contact: Will Johnson. Supera-CBD is being developed to address the rapidly growing CBD market, that includes FDA approved drugs and CBD products not currently regulated as a drug. About FTSE Russell.

Pharmaceutical 79

Pharmaceutical Clinical Trials CBD Banking 79

CannaMD

NOVEMBER 6, 2019

Perhaps the commercialization of marijuana and the favorable media coverage surrounding the health effects of marijuana are fostering such a perception. Some of the more interesting data on the relationship between opioids and medical marijuana for pain management comes from the field of orthopedic surgery. million to 11.4

Marijuana 88

Marijuana Patients Clinical Trials Data 88

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor. Throughout the 20th century, the “stoner” stereotype was often portrayed in the media. Emerald Group Publishing Limited. Moscowitz, L.,

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

JULY 24, 2019

Our clinics are based on the premise that patients are treated by our world-renowned specialists in the relevant condition. It will be the first to have meaningful and consistent data of how medicinal cannabis has helped when properly prescribed as part of a full treatment pathway.”

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Cannabis Law Report

DECEMBER 15, 2021

In 2021, atai has achieved many major milestones, for example the promising phase 2a data for its schizophrenia drug RL-007 or the Phase 2b readout of Compass Pathways , of which atai owns 22.6% Constant change, misuse of social media, constant over-stimulation – all this is totally toxic for our brain and taking its toll on us all.

Research and Development 52

Research and Development Data History Patients 52